CalciMedica, Inc. Stock
Stocks
CALC
US38942Q3011
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Nasdaq
2026-10-27
|
5-day change | 1st Jan Change | ||
| 1.310 USD | +0.77% |
|
+6.50% | -96.02% |
| Market Cap | 9.97M 8.93M 8.21M 7.44M 13.91M 947M 14.17M 97.94M 39.32M 498M 37.41M 36.62M 1.57B | P/E 2026 * |
-0.48x | P/E 2027 * | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 9.97M 8.93M 8.21M 7.44M 13.91M 947M 14.17M 97.94M 39.32M 498M 37.41M 36.62M 1.57B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
81.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CALC | End-of-day quote | |
OTC Markets
| CALC | Delayed | |
|
CBOE
| CALC | Real-time |
| 1 day | +0.77% | ||
| 1 week | +6.50% | ||
| Current month | -19.14% | ||
| 1 month | -19.14% | ||
| 3 months | -68.81% | ||
| 6 months | -55.59% | ||
| Current year | -96.02% |
| 1 week | 1.25 |  | 1.84 |
| 1 month | 1 | | 1.84 |
| Current year | 1 | | 36 |
| 1 year | 1 | | 36 |
| 3 years | 1 | | 41.9 |
| 5 years | 1 | | 42.95 |
| 10 years | 1 | | 42.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 73 | 2007-03-31 | |
Rachel Leheny
CEO | Chief Executive Officer | 63 | 2019-08-31 |
Michael Dunn
PSD | President | 70 | 2013-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Wilson
CHM | Chairman | 85 | 2023-03-19 |
Rachel Leheny
CHM | Chairman | 63 | - |
Frédéric Guerard
BRD | Director/Board Member | 54 | 2023-03-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Free | Director | 20,000 | 0.2929% | ||
| 10/1/26 | Free | Director | 20,000 | 0.2929% | ||
| 10/1/26 | Free | Director | 20,000 | 0.2929% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.77% | +6.50% | -91.24% | -88.80% | 9.97M | |
| -0.62% | -1.87% | +46.31% | +56.99% | 63.77B | |
| +0.35% | +3.20% | +14.92% | +84.55% | 56.37B | |
| +0.53% | +1.96% | +15.37% | +106.81% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +50.90% | 44.06B | |
| -0.33% | -1.93% | +20.15% | +98.45% | 42.11B | |
| +0.55% | +2.31% | +224.97% | +942.56% | 41B | |
| +3.27% | +47.96% | +112.67% | +96.48% | 34.92B | |
| +1.22% | -1.44% | +14.89% | +47.15% | 32.82B | |
| +0.89% | +20.55% | -42.03% | +373.03% | 24.7B | |
| Average | +0.38% | +8.18% | +33.95% | +176.81% | 39.44B | |
| Weighted average by Cap. | +0.18% | +5.44% | +48.50% | +186.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -12.75M -11.41M -10.5M -9.51M -17.78M -1.21B -18.12M -125M -50.26M -637M -47.83M -46.82M -2.01B | -27.1M -24.27M -22.33M -20.23M -37.82M -2.57B -38.53M -266M -107M -1.35B -102M -99.56M -4.27B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$1.460 | -16.57% | 112,192 |
| 26-10-29 | US$1.750 | +5.42% | 107,456 |
| 26-10-28 | US$1.660 | +26.72% | 211,501 |
| 26-10-27 | US$1.310 | +0.77% | 40,377 |
| 26-10-26 | US$1.300 | +5.69% | 157,985 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CALC Stock
Select your edition
All financial news and data tailored to specific country editions
